For in vitro diagnostic (IVD) use as quality controls, to monitor the precision and accuracy of the Lumipulse G SARS-CoV-2 S-IgG assay on the automated LUMIPULSE G System. The assay using this control is performed to quantitatively measure IgG antibodies to SARS-CoV-2 Spike (S) Receptor Binding Domain (RBD) in human serum or plasma and is intended to be used in the assessment of the immune response to the SARS-CoV-2 S protein.
Lumipulse® G SARS-CoV-2 S-IgG Controls
2 x 2 levels
Please contact your local Fujirebio representative for the availability of this product in your country.